Bispecific HIV-1-neutralizing antibodies
US12098187B2 · kind B2 · utility
0Cited by
8References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2018 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | Sep 27, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In various embodiments, the present invention relates generally to using bispecific antibodies in the prevention and treatment of HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.